TE_112
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L2a_3end |
|---|---|
| TE superfamily | L2 |
| TE class | LINE |
| Gene | ENSG00000284646 |
| Class | Annoated |
| Coding | Non-coding |
| Tumor-specific score | 2.12 |
| Counts of samples | TCGA_tumor:63; TCGA_normal:11; GTEx:22 |
| TSS | chr1(-):11319092 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_112.1 | ENSG00000284646 | Annoated | Non-coding | Non-coding | chr1(-):11311949,11311969,11312256,11312403,11314605,11314875,11319007,11319093 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
